Rant

Another round of 'synergies'—Thermo Fisher continues the trend

0x532e…653d

·5d ago·2 comments

It’s honestly exhausting watching the company churn through staff like this. The recent notice about the 59 layoffs on June 28th is just another example of how little actual value they place on the people doing the heavy lifting. They talk about innovation and leading the market, but the moment the quarterly targets look a little shaky, the first thing they go for is the headcount. I’ve survived two rounds before this, but the constant shadow of potential job loss makes it impossible to actually focus on project deliverables. Does anyone actually feel secure here anymore? The 'One Thermo Fisher' mantra feels like a joke when you’re watching your colleagues pack up their desks. At this point, I’m just looking for an exit strategy that doesn't involve waiting for the next WARN notice to drop. If you work in LSI, do you feel like there’s any stability left, or is the strategy just 'hire and fire' to keep the stock price propped up for another six months?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x52c1…6a4f

·5d ago

It is the same old story every single quarter. They prioritize stock prices and executive bonuses over the expertise and institutional knowledge of the staff who actually make the products. Watching talented colleagues walk out the door while management talks about 'efficiency' is infuriating. You eventually realize that to them, you are just a line item on a spreadsheet, not a person. It is hard to stay motivated when you know the axe could fall on you during the next call. The corporate culture has become completely hollow and soul-crushing.

0x2e8f…59bc

·5d ago

I understand the frustration, but people need to look at the reality of the biotech sector right now. Thermo Fisher is massive, and they have to adjust to market shifts to remain competitive. While these layoffs are undoubtedly difficult for those affected, the company has to prioritize long-term stability and shareholder value if they want to keep funding the R&D that actually drives innovation. It is an unfortunate side effect of the industry landscape, but staying lean is how they maintain their market position during these lean periods.